Bruce L Levine

24PUBLICATIONS
167CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Gregory M Chen, Ankita Jain, David T Gering

|Oct 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

Ángel Ramírez-Fernández, Alexander J Dimitri, Fang Chen

|Jan 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Julie K Jadlowsky, Elizabeth O Hexner, Amy Marshall

|Nov 13, 2024
TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell function.

Alexander J Dimitri, Amy E Baxter, Gregory M Chen

|Jul 17, 2024
Regulatory Considerations for Genome-Edited T-cell Therapies.

Julie K Jadlowsky, Ju-Fang Chang, David H Spencer

|Jan 24, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.

Guido Ghilardi, Joseph A Fraietta, James N Gerson

Pageof 4

Frequent Collaborators

19 joint publications

Carl H June

8 joint publications

Joseph A Fraietta

8 joint publications

Jan Joseph Melenhorst

7 joint publications

Donald L Siegel